Sherritt International Corporation (“Sherritt” or the “Corporation”) (TSX:S) today announced its fourth quarter and full year 2025 production results. During the fourth quarter 2025, Sherritt received ...
HongKongExchangesandClearingLimitedandTheStockExchangeofHongKongLimitedtakenoresponsibilityforthecontentsofthisannouncement ...
Reported rinzimetostat (formerly ORIC-944) Phase 1b data that continue to demonstrate potential best-in-class efficacy and safety in mCRPC; selected provisional RP2Ds and initiated dose optimization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results